These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 18838500)

  • 21. Preferential D2 or preferential D3 dopamine agonists in restless legs syndrome.
    Manconi M; Ferri R; Zucconi M; Clemens S; Giarolli L; Bottasini V; Ferini-Strambi L
    Neurology; 2011 Jul; 77(2):110-7. PubMed ID: 21715702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial.
    Barone P; Poewe W; Albrecht S; Debieuvre C; Massey D; Rascol O; Tolosa E; Weintraub D
    Lancet Neurol; 2010 Jun; 9(6):573-80. PubMed ID: 20452823
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proerectile effects of dopamine D2-like agonists are mediated by the D3 receptor in rats and mice.
    Collins GT; Truccone A; Haji-Abdi F; Newman AH; Grundt P; Rice KC; Husbands SM; Greedy BM; Enguehard-Gueiffier C; Gueiffier A; Chen J; Wang S; Katz JL; Grandy DK; Sunahara RK; Woods JH
    J Pharmacol Exp Ther; 2009 Apr; 329(1):210-7. PubMed ID: 19136638
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment with medications affecting dopaminergic and serotonergic mechanisms: effects on fluency and anxiety in persons who stutter.
    Stager SV; Calis K; Grothe D; Bloch M; Berensen NM; Smith PJ; Braun A
    J Fluency Disord; 2005; 30(4):319-35. PubMed ID: 16246409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pramipexole effects on startle gating in rats and normal men.
    Swerdlow NR; Lelham SA; Sutherland Owens AN; Chang WL; Sassen SD; Talledo JA
    Psychopharmacology (Berl); 2009 Sep; 205(4):689-98. PubMed ID: 19506839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amantadine augmentation therapy for obsessive compulsive patients resistant to SSRIs-an open-label study.
    Stryjer R; Budnik D; Ebert T; Green T; Polak L; Weizman S; Spivak B
    Clin Neuropharmacol; 2014; 37(3):79-81. PubMed ID: 24824662
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sulpiride and refractory panic disorder.
    Nunes EA; Freire RC; Dos Reis M; de Oliveira E Silva AC; Machado S; Crippa JA; Dursun SM; Baker GB; Hallak JE; Nardi AE
    Psychopharmacology (Berl); 2012 Sep; 223(2):247-9. PubMed ID: 22864966
    [No Abstract]   [Full Text] [Related]  

  • 28. Antidepressant effects of pramipexole, a dopamine D3/D2 receptor agonist, and 7-OH-DPAT, a dopamine D3 receptor agonist, in olfactory bulbectomized rats.
    Breuer ME; Groenink L; Oosting RS; Buerger E; Korte M; Ferger B; Olivier B
    Eur J Pharmacol; 2009 Aug; 616(1-3):134-40. PubMed ID: 19549514
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Using prepulse inhibition to detect functional D3 receptor antagonism: effects of WC10 and WC44.
    Weber M; Chang WL; Durbin JP; Park PE; Luedtke RR; Mach RH; Swerdlow NR
    Pharmacol Biochem Behav; 2009 Aug; 93(2):141-7. PubMed ID: 19426754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Single dose of a dopamine agonist impairs reinforcement learning in humans: behavioral evidence from a laboratory-based measure of reward responsiveness.
    Pizzagalli DA; Evins AE; Schetter EC; Frank MJ; Pajtas PE; Santesso DL; Culhane M
    Psychopharmacology (Berl); 2008 Feb; 196(2):221-32. PubMed ID: 17909750
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Critical review of ropinirole and pramipexole - putative dopamine D(3)-receptor selective agonists - for the treatment of RLS.
    Varga LI; Ako-Agugua N; Colasante J; Hertweck L; Houser T; Smith J; Watty AA; Nagar S; Raffa RB
    J Clin Pharm Ther; 2009 Oct; 34(5):493-505. PubMed ID: 19744006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of pramipexole on the processing of rewarding and aversive taste stimuli.
    McCabe C; Harwood J; Brouwer S; Harmer CJ; Cowen PJ
    Psychopharmacology (Berl); 2013 Jul; 228(2):283-90. PubMed ID: 23483198
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pramipexole at a Low Dose Induces Beneficial Effect in the Harmaline-induced Model of Essential Tremor in Rats.
    Kosmowska B; Wardas J; Głowacka U; Ananthan S; Ossowska K
    CNS Neurosci Ther; 2016 Jan; 22(1):53-62. PubMed ID: 26459182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serotonin and sensitivity to trauma-related exposure in selective serotonin reuptake inhibitors-recovered posttraumatic stress disorder.
    Corchs F; Nutt DJ; Hood S; Bernik M
    Biol Psychiatry; 2009 Jul; 66(1):17-24. PubMed ID: 19268914
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anxiolytic-like effect of quinpirole in combination with a low dose of 17β-estradiol in ovariectomized rats.
    Fedotova J
    Acta Physiol Hung; 2013 Jun; 100(2):211-23. PubMed ID: 23708948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term administration of the dopamine D3/2 receptor agonist pramipexole increases dopamine and serotonin neurotransmission in the male rat forebrain.
    Chernoloz O; El Mansari M; Blier P
    J Psychiatry Neurosci; 2012 Feb; 37(2):113-21. PubMed ID: 22023785
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pramipexole in treatment-resistant depression: a 16-week naturalistic study.
    Lattanzi L; Dell'Osso L; Cassano P; Pini S; Rucci P; Houck PR; Gemignani A; Battistini G; Bassi A; Abelli M; Cassano GB
    Bipolar Disord; 2002 Oct; 4(5):307-14. PubMed ID: 12479663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pramipexole for bipolar II depression: a placebo-controlled proof of concept study.
    Zarate CA; Payne JL; Singh J; Quiroz JA; Luckenbaugh DA; Denicoff KD; Charney DS; Manji HK
    Biol Psychiatry; 2004 Jul; 56(1):54-60. PubMed ID: 15219473
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the efficacy of pramipexole for treating levodopa-induced dyskinesia in patients with Parkinson's disease.
    Utsumi H; Okuma Y; Kano O; Suzuki Y; Iijima M; Tomimitsu H; Hashida H; Kubo S; Suzuki M; Nanri K; Matsumura M; Murakami H; Hattori N;
    Intern Med; 2013; 52(3):325-32. PubMed ID: 23370739
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of pramipexole and modafinil on arousal, autonomic, and endocrine functions in healthy volunteers.
    Samuels ER; Hou RH; Langley RW; Szabadi E; Bradshaw CM
    J Psychopharmacol; 2006 Nov; 20(6):756-70. PubMed ID: 16401653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.